Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05037825
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:41.702460+00:00
Published At
2022-04-27T00:00:00+00:00
Record Updated At
2022-04-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-Small-Cell Lung Carcinoma", "Malignant Melanoma", "Renal Cell Carcinoma", "Triple-Negative Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-04-27"
protocolSection.identificationModule.nctId
"NCT05037825"
protocolSection.identificationModule.officialTitle
"The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-Small-Cell Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • Malignant Melanoma (protocolSection.conditionsModule.conditions)
  • Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Triple-Negative Breast Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.